Literature DB >> 26369529

[Toxic megacolon].

M Leppkes1, M Ganslmayer1, R Strauß1, M F Neurath2.   

Abstract

BACKGROUND: Toxic megacolon constitutes a feared, life-threatening complication of severe intestinal inflammation and is a challenge for interdisciplinary medical care.
OBJECTIVES: Specific aspects of conservative treatment based on current scientific evidence derived from guidelines, qualified reviews, and scientific studies are presented, which provide a rational approach and maximize therapeutic success.
MATERIALS AND METHODS: This work is based on a selective literature review and the authors' experience of many years in gastroenterology and intensive care.
RESULTS: Toxic megacolon requires a rapid interdisciplinary assessment. Depending on the underlying etiology, an individual treatment concept needs to be developed. If an infectious or inflammatory cause is probable, a conservative approach can reduce perioperative morbidity and mortality. A step-wise approach with controlled reevaluations of the response to therapy after 72 h and 7 days avoids uncontrolled delay of surgical options further ensuring patient safety.
CONCLUSION: Despite a decreasing incidence of toxic megacolon, it remains an interdisciplinary therapeutic challenge.

Entities:  

Keywords:  Clostridium difficile; Colitis, ulcerative; Cytomegalic inclusion disease; Intensive care; Pseudomembranous colitis

Mesh:

Year:  2015        PMID: 26369529     DOI: 10.1007/s00063-015-0076-1

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  17 in total

1.  The surgical management of toxic dilatation of the colon: a report of 28 cases and review of the literature.

Authors:  R J Strauss; G W Flint; N Platt; L Levin; L Wise
Journal:  Ann Surg       Date:  1976-12       Impact factor: 12.969

2.  [Updated German guideline on diagnosis and treatment of ulcerative colitis, 2011].

Authors:  A Dignass; J C Preiss; D E Aust; F Autschbach; A Ballauff; G Barretton; B Bokemeyer; S Fichtner-Feigl; S Hagel; K R Herrlinger; G Jantschek; A Kroesen; W Kruis; T Kucharzik; J Langhorst; M Reinshagen; G Rogler; D Schleiermacher; C Schmidt; S Schreiber; H Schulze; E Stange; M Zeitz; J C Hoffmann; A Stallmach
Journal:  Z Gastroenterol       Date:  2011-08-24       Impact factor: 2.000

Review 3.  Toxic megacolon.

Authors:  S G Sheth; J T LaMont
Journal:  Lancet       Date:  1998-02-14       Impact factor: 79.321

Review 4.  [Value of ultrasound in diagnostic and follow-up of chronic inflammatory bowel diseases].

Authors:  Horst Kinkel; Guido Michels; Natalie Jaspers
Journal:  Dtsch Med Wochenschr       Date:  2015-01-12       Impact factor: 0.628

5.  The knee-elbow position relieves distension.

Authors:  D H Present
Journal:  Gut       Date:  1994-08       Impact factor: 23.059

6.  Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis.

Authors:  Xavier Roblin; Sylvie Pillet; Abderrahim Oussalah; Philippe Berthelot; Emilie Del Tedesco; Jean-Marc Phelip; Marie-Laure Chambonnière; Olivier Garraud; Laurent Peyrin-Biroulet; Bruno Pozzetto
Journal:  Am J Gastroenterol       Date:  2011-07-26       Impact factor: 10.864

7.  Duodenal infusion of donor feces for recurrent Clostridium difficile.

Authors:  Els van Nood; Anne Vrieze; Max Nieuwdorp; Susana Fuentes; Erwin G Zoetendal; Willem M de Vos; Caroline E Visser; Ed J Kuijper; Joep F W M Bartelsman; Jan G P Tijssen; Peter Speelman; Marcel G W Dijkgraaf; Josbert J Keller
Journal:  N Engl J Med       Date:  2013-01-16       Impact factor: 91.245

8.  Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial.

Authors:  Marc Gh Besselink; Hjalmar C van Santvoort; Erik Buskens; Marja A Boermeester; Harry van Goor; Harro M Timmerman; Vincent B Nieuwenhuijs; Thomas L Bollen; Bert van Ramshorst; Ben Jm Witteman; Camiel Rosman; Rutger J Ploeg; Menno A Brink; Alexander Fm Schaapherder; Cornelis Hc Dejong; Peter J Wahab; Cees Jhm van Laarhoven; Erwin van der Harst; Casper Hj van Eijck; Miguel A Cuesta; Louis Ma Akkermans; Hein G Gooszen
Journal:  Lancet       Date:  2008-02-14       Impact factor: 79.321

9.  Vedolizumab as induction and maintenance therapy for ulcerative colitis.

Authors:  Brian G Feagan; Paul Rutgeerts; Bruce E Sands; Stephen Hanauer; Jean-Frédéric Colombel; William J Sandborn; Gert Van Assche; Jeffrey Axler; Hyo-Jong Kim; Silvio Danese; Irving Fox; Catherine Milch; Serap Sankoh; Tim Wyant; Jing Xu; Asit Parikh
Journal:  N Engl J Med       Date:  2013-08-22       Impact factor: 91.245

10.  A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.

Authors:  Fred A Zar; Srinivasa R Bakkanagari; K M L S T Moorthi; Melinda B Davis
Journal:  Clin Infect Dis       Date:  2007-06-19       Impact factor: 9.079

View more
  3 in total

Review 1.  [Acute colonic pseudo-obstruction: Ogilvie syndrome].

Authors:  J Keller; P Layer
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-09-23       Impact factor: 0.840

Review 2.  Resolution of ulcerative colitis.

Authors:  Markus F Neurath; Moritz Leppkes
Journal:  Semin Immunopathol       Date:  2019-07-05       Impact factor: 9.623

3.  Gastrointestinal toxicities associated with immune checkpoint inhibitors: a disproportionality analysis leveraging VigiBase, the WHO Adverse Drug Reaction Database.

Authors:  Sifu Huang; Xuefeng Bai; Taiyong Fang; Yanta Guo; Kainan Zheng; Xiahong Lin
Journal:  J Zhejiang Univ Sci B       Date:  2021-02-15       Impact factor: 3.066

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.